The War on the Working Classes and Elderly
We have had a very cold and rainy, stormy spring. Until this week your daily temperatures were much higher than our AVERAGE temps have been 4.4 C. We did have about two or three days of 15 C.
The Politics are very depressing with mostly name calling and very little rational discussion. The governor of Michigan and the Legislature are in Republican Hands. The Republican Party National and State with the support of the Chamber of Commerce (Handelskammer) have declared was on the working classes and Senior Citizens. The first objectives is the reduce medical coverage, giving the Insurance Companies the Power to refuse coverage for previous conditions and to cancel coverage at the digression of the insurance companies.
They are planning to cut payments to providers. This will have the consequence of Dr. and Hospitals to refuse to accept Medicare, which already has happened with Medicaid the Insurance coverage for the poor. I will also result in Hospitals and Dr. to give less service to the Medicare Enrollees. With the agreement of Medicare Hospitals will be forced to discharge patients early over the objections of their doctors.
We have had a very cold and rainy, stormy spring. Until this week your daily temperatures were much higher than our AVERAGE temps have been 4.4 C. We did have about two or three days of 15 C.
The Politics are very depressing with mostly name calling and very little rational discussion. The governor of Michigan and the Legislature are in Republican Hands. The Republican Party National and State with the support of the Chamber of Commerce (Handelskammer) have declared was on the working classes and Senior Citizens. The first objectives is the reduce medical coverage, giving the Insurance Companies the Power to refuse coverage for previous conditions and to cancel coverage at the digression of the insurance companies.
They are planning to cut payments to providers. This will have the consequence of Dr. and Hospitals to refuse to accept Medicare, which already has happened with Medicaid the Insurance coverage for the poor. I will also result in Hospitals and Dr. to give less service to the Medicare Enrollees. With the agreement of Medicare Hospitals will be forced to discharge patients early over the objections of their doctors.
The Fraudalent 2010 elections
The 2010 elections were notable by the lack of rational discount on the part of the Republican Party, supported by the Chambers of Comerce. In all elections the Republican Party and literature from the Chambers both national and state, atttacked their oponents with lies instead of discussing the issues. Therefore we are not bound by laws of lliving in a democratic country, because the elections of the national House and many state legislatures of Republican majorities were obtained by lies. Rational citizens should united and beginn to recall all Republicans from all units of Government, In Michigan recall petitions of Governor Snyder are being prepared.
An Article on Evolution by Stephen R. Palumbi, Harvard University.
Return to Papers and ArticlesWhy Evolution Matters
by Stephen R. Palumbi, Harvard University
Society for the Study of EvolutionNABT Convention, Reno, NV, Nov.4, 1998
Why Evolution Matters
by Stephen R. Palumbi, Harvard University
Society for the Study of EvolutionNABT Convention, Reno, NV, Nov.4, 1998
There are abundant popular views about evolution. It isn't that most people wake up and stumble towards the coffee maker thinking, "Oh, man, what am I going to do about evolution today?" It is instead that evolution as a subject has become enough of a cultural common currency that most people feel comfortable having an opinion.
Among biological sciences, this is actually a somewhat enviable position--herpetologists (who study reptiles and amphibians) would give a year's supply of snake skins for the popular attention given evolution. But such attention has its bad points as well as good and does as much to complicate the understanding of evolution as it does to raise interest in the subject. Although many people have a deep understanding of evolution, several major misconceptions about evolution are so common as to seem like dogma. These misconceptions simultaneously raise a storm of controversy about evolution and prevent understanding of an increasingly important biological crisis riding the crest of a human-made evolutionary wave.
Evolution and the Origin of Species
A critical misconception is that "evolution" and "the origin of species" are exactly the same thing. Most discussions (or law suits) on the " theory of evolution" are really about the "theory of the origin of species due to evolution by natural selection." In fact, evolution by natural selection is a biological process that is abundantly documented by observations and experimental evidence. It is as much a scientific reality as nuclear fusion (and is easier and safer for the average person to observe).
Evolution by natural selection can be seen in many experimental situations. For example, fresh water guppies are eaten by larger predatory fish that tend to consume more brightly colored males than duller males. When predators are abundant, the result is an evolutionary shift, in just a generation or two, towards males with drab colors. But females prefer to mate with bright males (in terms of hue), so in the race for mates, colorful males dominate. These two types of selection, driven by predators and choosy mates, result in evolutionary shifts in color when ecological conditions change. When predators are common, dull colors predominate. In the absence of predators, gaudy males dance the stream beds to attract discerning mates.
Another example is the beak size of seed-eating finches living on dry islands in the Galapagos archipelago. During particularly dry years, plants do not produce many seeds. Finches live mainly on a diet of seeds and tend to consume smaller, softer seeds first. As the small seed supply is consumed, finches are left with the chore of cracking into harder, larger seeds. Birds with the smallest beaks can not do this well. As a result, during drought years birds with small beaks may well starve, leaving populations dominated by larger members of a species. Years with unusual weather thus lead to populations of unusual finches.
To such examples of natural selection can be added many examples of artificial selection conducted in laboratory settings or by selection for particular characteristics by plant and animal breeders. In virtually every experiment in which a sufficiently large and variable population is culled by artificial selection, an evolutionary response is observed. This response has been used countless times in the domestication of animals and plants. Long before Darwin recognized this as an evolutionary response, it had been used to shape the nature of agriculture. To be fair, there are limits to this response and sometimes there are unforeseen consequences. One fruit fly biologist tried to select for resistance to high temperatures by eliminating flies that passed out and fell off a heated cylinder. Instead, he ended up selecting for flies that passed out but hung tenaciously and unconsciously onto the cylinder wall. Nevertheless, evolution by natural or artificial selection is a biological phenomenon that's easily and rigorously demonstrated. One area of active research is how evolution by natural selection leads to the formation of new species. Darwin envisioned that evolutionary "adaptation" in changing environments could lead to divergence of new species from their ancestors. Other mechanisms of species formation have also been envisioned (Mayr, etc.), and processes by which particular species form are often hotly debated. This is because speciation is not as easily observable or experimentally demonstrable as is simple evolutionary change.
This is not to say that speciation is an inexplicable process. Indeed, the dominant view of species evolution, the gradual divergence of populations in separate geographic locales, has been observed experimentally. However, successful experiments in species formation are rather rare They take a long time and result in small shifts in morphology or behavior compared to species observable in the wild.
In a few cases, mechanisms of species formation have been observed. Abrupt shifts in behavior can result in species boundaries. Tephridid fruit flies lay their eggs on ripening fruit, and often females have highly discriminating tastes about which fruits are the best for their larvae. In the late 1800s, flies that lived on Hawthorn fruit in North America developed an egg-laying preference for apples introduced for agriculture. The shift in preference is heritable - daughters of apple-loving flies also lay eggs on apples - and so a new race or species became established. How different are these species? It takes an expert to tell them apart. But the potential now exists for these two types of flies to evolve separately, gradually diverging in defining characteristics, some important, some not, some visible, some depending on deep physiological or biochemical differences.
Because speciation is so difficult to study, understanding it has long been a primary evolutionary quest. It is a subject rich in experimental possibilities and theoretical convolutions, and it draws heavily on what we know about evolution by natural selection. But "evolution" and "speciation" are not the same, and uncertainties about the how the latter occurs do not mar our increasing understanding of the former. In addition, the impact of humans on the biological world around us does not hinge on species formation. Instead it hinges on evolutionary shifts in diseases and insect pests and the plants we raise for food. So we must move on to consider the second common misconception about evolution - the one that matters most - the speed of evolutionary change.
The Speed of Evolution
The dinosaurs evolved and ruled the earth for over 100 million years, succumbing finally in theaftermath of an asteroid strike 65 million years ago. Over tens of millions of years, different forms arose and went extinct. The plastic stable of species familiar in toy chests of most 5 year-olds (Triceratops, Stegosaurus, Apatosaurus, Tyrannosaurus) slowly came and went on the evolutionary stage. And so evolution seems a majestic and slow process, minutely ticking away during vast stretches of time. Infinitesimally - different generations are strung together long enough so that, while the mountains wear away and the very continents plow the seas, species evolve new forms.
Darwin thought this way too. Evolution by natural selection was born as an idea in the early decades of the 19th century, when the age of the earth was considered to be immense--so large that tiny, random variations could slowly be selected for during the struggle for survival. In fact, a debilitating challenge to the theory of evolution by natural selection came from calculations of physicists who concluded in the late 1800s that the Earth was cooling so fast that life could be no older than 20-40 million years. Darwin was dismayed by this time frame - too short for his view of slow evolution to play out - and died before the discovery of heat-producing radioactive decay could over-turn these objections.
To find examples of evolution, Darwin and his predecessors tended to scan large tracts of time. They saw in the stately change of the fossil record or in the fine-tuned adaptation of precise biological machinery the signature of evolution over the millennia.
So, too, modern accounts of evolution often emphasize missing-link fossils from long ago and the happenings (especially for the Hollywood fossils--the dinosaurs) of tens of millions of years in the past. Yet biologists have long noticed rapid evolutionary change, both within the fossil record and in modern plants and animals. Sometimes studied for their value as exceptions to the slow evolutionary rule, sometimes studied for purely practical reasons, rapid evolution is increasingly well-known. We no longer need to dig into Earth's rocky past to uncover evolutionary events, but we can turn to the modern world around us. And once we begin to look for active evolution, we can find it all around us. In the signature of every harsh winter, every drought summer, every invasion of a new pest and every dose of antibiotics, there is an evolutionary twist, a shift toward a new way of living. Perhaps the shift will be short-lived like this year's rain hydrating last year's drought, as one evolutionary shift cancels out the previous. But also perhaps the chance evolution of a resistant bacterial strain could create a plague or require a billion-dollar search for a novel antibiotic.
To understand this speed requires an understanding of evolution's engine - the interlocking gears and power train that drives change across the generations. We need to understand what connects the engine's parts and why they work together. We need to understand why sometimes the engine runs quickly and sometimes slowly - why it races and why it stalls. And once we do understand it's function we can apply that intuition to the world around us and to the evolutionary events that transpire every day. The power of evolutionary science to explain and the power to predict will then let us organize our effect on the biological world to take inevitable evolutionary change into account. This change is all around us already, but we cast it as an adversary - a facet of the biological world to tame. Tame it we can, but not without understanding, and not all the time.
If Evolution is Fast
If evolution is fast then humans are the most crucial evolutionary force ever unleashed on the planet. This is because we change the world rapidly and repeatedly. We create new environments by the way we live, we create new biological hurdles by the way we protect our crops or cure our diseases. We change what the best strategies are for successful reproduction of other species by choosing when to hunt for them or harvest them or when to disturb the environments they live in. We also have created a world-wide transportation web that is virtually instantaneous compared with "natural" means of movement for most species. Like the asteroid strike that spelled doom for the last of the dinosaurs, we have dramatically altered the biological stage. The landscape and seascape have changed more radically in the past fifty years than virtually any time in the past. And it does not take an intelligent species to respond to the new human world - it does not take planning and forethought, committees and blueprints. All it takes is selection of individuals better adapted to these new environments. All it takes is for the progeny of these selected individuals to inherit these new abilities.
Evolution of antibiotic resistance
Remember the pediatrician's stain-resistant office, and the shrill sounds of crying. You have a baby, and this means that bodily secretions are now acceptable dinner conversation. But when a cold strikes in those tiny airways, the clog of all those secretions overwhelms even the most stoic parent. What fate awaits the pediatrician's decision? What antibiotic will she give baby for the cold? The increasingly likely answer - none.
In small children, a large fraction of chest and head colds are viral. A good pediatrician will not always prescribe antibiotics for colds - but often waits for them to clear naturally. The reason is an evolutionary one - too frequent use of antibiotics selects for resistance. And when a bacterial infection does strike, it would be better if the bacteria hadn't already evolved to eat antibiotics. This ushers in the new medicine, a set of procedures that assumes that evolution will happen, and will happen fast. Part of the current strategy requires withholding medications when not needed, and part of the current problem remains incorrect patient use of the medications that cure.
It hasn't always been this way. The first antibiotics were hailed as the wonder drugs of the 20th century (despite having been described in the Bible - then discovered and forgotten by Pasteur and Belgian scientists). Finally rediscovered by Alexander Flemming in 1928 and used extensively in World War II, penicillin was crystalline death to most infections. But by 1947 the first strong resistance emerged. Since then, the arms race has been fierce, expensive, continuous, and usually won by bacteria. A zodiac of different drugs have been invented by humans and Houdini'ed by bacterial escape artists. Some of the best ones are now reserved as the drugs of last resort -withheld from all but the worst infections. The evolutionary engine dictates this strategy, as well as the emergence of evolutionary medicine as a clever treatment method. Thus, medicine can no longer afford to ignore the fact of evolution and instead has begun to define treatment protocols that 1) assume evolution will occur, and 2) limit the opportunity for evolution as much as possible.
Other examples
There are many other examples of rapid evolution in the biological world around us: HIV virusesevolving within a single person during the course of AIDS, evolution of small body size and new reproductive tactics in over-fished salmon, the evolution of insects to insecticides, including those genetically engineered into crop plants. These examples provide a source of insightful information about the evolutionary process, and show how important evolution has become to our modern society. These examples can be very personal, deal with daily lives of many of us, and thus may be a powerful tool in teaching evolution at many levels.
Moves in Congress to give the Department of Veterans Affairs as much as $3.8 billion more than the Bush administration proposed has drawn an indirect veto threat from the White House."If Congress increases VA funding above the president's request and does not offset this increase with spending reductions in other bills, the president will veto any of the other bills that exceed his request until Congress demonstrates a path to reach the president's top line of $933 billion," the Office of Management and Budget said in a statement.
The great supporter of our troops.
The way to fund this important bill to repeal the tax cuts and increase the tax on all incomes over $200,000.00.
Labels: Our wounded Veterans betrayed by the President.
CRIMES AGAINST THE PEOPLE
The President continues his stubborn path of obstructionist tactics to thwart the will of the people. Our stay in Iraq unfortunately has many echoes of Viet Nam. The Body Counts, the attacks on Newspapers and the optimistic assessment of where we are in Iraq are danger signals. The reality is that our forces are in the midst of a civil war between to God believing groups each believing they have the keys to the kingdom.
I does not matter that the God's they worship do not exist and have no basis in reality, they kill each other never the less, Just as the Christians killed each other in the European Religious wars.
Unfortunately I see no resolution to such a conflict. Even the introduction of massive force will not dampen the enthusiasm of the slaughter. So it seems our only rational action is to leave and save our young men from being murdered in this fantatical franticide.
The war has nothing to do with terrorism will not endanger us. It may help us to make more friends among the moderate Arabs.
I call for indictments and trials of all involved. The bottom line is not a measure of moral behaviour.
From the Detroit Free Press May 22, 2007
Secret test gave patients a substitute for blood
In Detroit, one of 9 died; U.S. agency is investigating
May 22, 2007
BY STEVE NEAVLING
FREE PRESS STAFF WRITER
You're in a car crash, unconscious and bleeding profusely.
Without your consent, you are injected with an experimental blood substitute being randomly tested on victims of car crashes, shootings and other trauma. That's exactly what happened to nine trauma patients -- one of whom died -- at two Detroit hospitals last year.
Nine other patients randomly selected to receive the standard treatment -- saline solution and real blood -- survived.
The blood substitute, Polyheme, was tested in 20 cities.
The U.S. Food and Drug Administration is investigating 46 deaths nationwide among the 349 subjects who received Polyheme in the clinical trial. By contrast, 35 of the 363 patients given the standard treatment died.
In most clinical studies, patients must volunteer, usually doing so with the hope of being cured through the experimental treatment.
But the Polyheme trial was one of 15 no-consent studies permitted by the FDA since 1996, when it began allowing researchers to enroll patients in clinical tests without their permission if the treatment showed enough potential to save lives.
Some medical ethicists are outraged at the Polyheme trial.
"This is completely unethical," said Dr. Sidney Wolfe, director of Public Citizen's Health Research Group. "They withheld blood -- the gold standard -- for a product that has proven in previous clinical circumstances to raise the death rate."
Inside the study
Northfield Laboratories of Evanston, Ill., Polyheme's manufacturer, contends there was no other way to test the product. Trauma patients are generally unconscious and cannot give consent.
"If I were injured, would I want Polyheme? Absolutely. I would prefer it," said Dr. Larry Diebel, who led the trials in Detroit and is a medical professor at Wayne State University. Detroit Receiving and Sinai Grace hospitals participated in the testing.Northfield maintains that there were violations of study protocols with nearly one-fifth of the participants. In some cases, it said, paramedics gave Polyheme to people who were going to die regardless of treatment.
The company plans to release a report as early as this month from a research organization it contracted with to review the data. In December, Northfield's data showed that if 122 questionable cases were excluded, the increase in the mortality rate for those who received Polyheme over those who received blood was just 18.7%. Without those cases being excluded, the rate was 49%.
To fill a critical need
Another no-consent study involving Hemopure, a similar blood substitute manufactured by Biopure of Cambridge, Mass., was halted in December by the FDA.. The agency raised concerns that the Navy personnel on whom the product was being tested were dying and suffering heart attacks.
The FDA declined to comment on the Polyheme study while it is reviewing it.
Advocates say Polyheme, which is made by extracting oxygen-carrying hemoglobin from human red blood cells, comes along at a time when the United States is facing a critical blood shortage.
Nationally, about 100,000 people die of bleeding injuries every year. Medical professionals say some deaths could be prevented if not for blood shortages.
The shortage of O-negative blood, the universal-donor blood type that can be administered to any patient, is especially acute. At southeastern Michigan hospitals, the demand for O-negative is so high that none is stockpiled, said Martha Kurz, spokeswoman for the American Red Cross of Southeastern Michigan.
A blood substitute such as Polyheme could be especially useful in combat because the product has a long shelf life and doesn't need to be refrigerated, researchers say.
Hemorrhaging remains a main cause of death on the battlefield, and the U.S. Army reports about 60% of those injured in Iraq suffered substantial blood loss.
Earlier problems
Northfield Laboratories was criticized in 2001 for a four-year Polyheme study on aneurysm-surgery patients.
Ten of 81 patients who were given the substitute suffered heart attacks, including two who died. None of the 71 patients on standard therapy had heart attacks.
The company blamed the heart attacks on an excess of total fluids given to Polyheme patients and halted the study.
The second trial was approved by the FDA, in part, because Northfield was testing Polyheme for a different purpose.
The Detroit Medical Center, which runs the two Detroit hospitals that participated in the second trial, said the lone fatality involved a man hit by an SUV. The DMC declined to comment further on the trial or give the names of the patients, citing privacy laws.
Diebel, the trials' leader in Detroit, said all of the Detroit hospitals' patients were victims of shootings or car crashes and were between the ages of 19 and 55.
He said he believes Polyheme is a breakthrough in emergency medicine. In addition to being compatible with all blood types and storing longer than blood, it is virtually free of viral transmission.
Northfield Laboratories saw its stock plummet 75% after the December disclosure of the death rate, prompting a class action by investors who claim they were never told about the number of heart attacks in the first study.
Contact STEVE NEAVLING at 586-469-4935 or
sneavling@freepress.com.
Copyright © 2007 Detroit Free Press Inc.
if(typeof gcion_enable_bt != 'undefined') {
if(gcion_enable_bt) {
document.writeln('');
}
}
if(typeof gcion_enable_bt != 'undefined') {
if(gcion_enable_bt) {
var gciYear = 2007;
DM_addToLoc("zipcode", escape(s.prop30));
DM_addToLoc("age", escape((gciYear-s.prop31)));
DM_addToLoc("gender", escape(s.prop32));
DM_tag();
}
}
=0)document.write(unescape('%3C')+'\!-'+'-')
//-->
Initializing : 78ms
Starting first parse
Retrieve categories: 0ms
Read templates: 0ms
Read objects: 0ms
Scripts: 0ms
Read cache: 16ms
-->
Secret testing violates trust
May 23, 2007
The "yuck" factor already is pretty high with Polyheme, a radical blood substitute that conjures up images of cyborg medicine using synthetic fluids.
But add to that the fact that hospitals -- including two in this area -- used this
stuff in a trial on unsuspecting (and non-consenting) trauma victims, sometimes with fatal results, and the outrage factor runs high, too. Who ever thought this was a good idea?
The concept may well have merit. Blood donorship has its peaks and valleys, and in combat situations especially, a ready substitute could prove miraculous -- even though it sounds icky.
But secret tests on patients?
History is full of cautionary tales about the dangers therein, and the mistrust these kinds of experiments almost always engender. It's tough enough to trust doctors and the medical establishment, difficult still for many people to have faith that their lives are in the best hands.
Clandestine trials of something so vital as artificial blood can only exacerbate the discomfort.
It doesn't help at all that Polyheme, in addition to providing a substitute for red blood cells, also appears to agitate blood vessels, sometimes causing heart attacks. Those heart problems caused 46 deaths nationwide, and one locally.
The Food and Drug Administration has pretty strict rules for no-consent trials, and at least in theory, Polyheme would qualify. But that still doesn't make it a smart way to try such an invasive and, apparently, risky product.
The fallout from Polyheme's troubles should inspire the FDA to rethink how medical innovation is pursued.
Copyright © 2007 Detroit Free Press Inc.
if(typeof gcion_enable_bt != 'undefined') {
if(gcion_enable_bt) {
document.writeln('');
}
}
if(typeof gcion_enable_bt != 'undefined') {
if(gcion_enable_bt) {
var gciYear = 2007;
DM_addToLoc("zipcode", escape(s.prop30));
DM_addToLoc("age", escape((gciYear-s.prop31)));
DM_addToLoc("gender", escape(s.prop32));
DM_tag();
}
}
=0)document.write(unescape('%3C')+'\!-'+'-')
//-->
Initializing : 296ms
Starting first parse
.Build 3: 1138 ms (Article)
.Parsing macro sitecatalyst
..Build 3: 234 ms (Article)
.Completed macro sitecatalyst
.Build 9: 265 ms (Content)
Retrieve categories: 16ms
Read templates: 63ms
Read objects: 310ms
Scripts: 720ms
Starting second parse
Retrieve categories: 0ms
Read templates: 0ms
Read objects: 0ms
Scripts: 0ms
-->
Labels: Drug administered without informed consent
Today we see the terrible consequences of pro business administrative practices and government agency colloboration with criminal corporations.
The following MedWatch article speaks for itself. Help to defend us from e-coli, and plastic poison outbreaks by demanding the restoration and funding of controls over the health industrial giants.
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01617.htmlFDA Home Page Search FDA Site FDA A-Z Index Contact FDAFDA News
FOR IMMEDIATE RELEASEP07-73April 25, 2007
Media Inquiries: Kimberly Rawlings, 301-827-6242Consumer Inquiries: 888-INFO-FDA
Major Manufacturer of Unapproved and Adulterated Drugs Agrees to Stop Illegal Practices
The U.S. Food and Drug Administration (FDA) announced the entry of a Consent Decree of Permanent Injunction against PharmaFab Inc., its subsidiary, PFab LP, and two company officials, Mark Tengler, PharmaFab's president, and Russ McMahen, PFab's vice president of scientific affairs, to stop the illegal manufacture and distribution of prescription and over-the-counter drug products. The products are illegal because they are not produced according to the required current good manufacturing practice (CGMP) and many also lack required FDA approval. The case was filed in the United States District Court for the Northern District of Texas.
“Drug approval and CGMP compliance are part of the foundation of drug safety,” said Steven K. Galson, M.D., M.P.H, director of FDA’s Center for Drug Evaluation and Research (CDER). “When companies and individuals choose not to comply with the law, FDA must deal with these problems decisively.”
PharmaFab is a major contract manufacturer and distributor of more than 100 different prescription and over-the-counter drug products, including cough and cold products, ulcer treatments, and postpartum hemorrhage products. Consumers who have products manufactured by PharmaFab should consult with their physician.
The unapproved drugs manufactured by PharmaFab include, but are not limited to:
De-Congestine Sustained Release Capsules;
GFN 1200/DM 60/PSE 60 Extended-Release Tablets;
Rhinacon A Tablets;
Sudal 12 Chewable Tablets;
Histex PD 12 Suspension;
Atuss HX CIII;
Ergotrate Tablets; and Hyoscyamine Sulfate Time-Release Capsules.
Because these drugs have not undergone FDA approval, their safety and effectiveness have not been established, and FDA has not reviewed the adequacy and accuracy of the directions and warnings in their labeling.
According to the complaint filed with the court, PharmaFab did not comply with CGMP by not investigating manufacturing failures and not recording and justifying why it deviated from written manufacturing procedures. Further, the company lacked an effective quality control unit and failed to establish reliable expiration dates for products. Compliance with CGMP is necessary to ensure that drugs have the requisite safety, identity, strength, quality, and purity.
The consent decree requires the defendants to destroy certain illegal drugs, and bars them from distributing all drugs until they obtain required FDA approval and fully comply with CGMP. If they resume distributing drugs, the defendants are required to retain an auditor to conduct inspections of their facilities for a period of five years and to provide reports to FDA analyzing compliance with CGMP and labeling requirements. The decree also allows FDA to require recall or shutdown in the event of future violations and provides for damages of $5,000 per day and $1,000 per violation, up to a maximum of $5 million per year, if the defendants fail to comply with its terms.
“FDA will not hesitate to pursue enforcement action when necessary,” said Margaret O’K. Glavin, FDA's associate commissioner for regulatory affairs. “We will continue to protect public health by carefully monitoring the provisions of this injunction. FDA will also continue to investigate and take action against other marketers of unapproved drugs.”
In June 2006, FDA issued a guidance document entitled, “Marketed Unapproved Drugs—Compliance Policy Guide” (CPG). The CPG makes clear that firms may not market drugs that require approval without first establishing in applications that the products are safe and effective. One of the priorities in this CPG is enforcement actions against manufacturers that violate other provisions of the Federal Food, Drug, and Cosmetic Act.
For more information:
FDA’s ongoing efforts on marketing unapproved drugs
www.fda.gov/cder/drug/unapproved_drugsCDER’s Web page on Compliance with Current Good Manufacturing Practices
http://www.fda.gov/cder/dmpq.
####
RSS Feed for FDA News Releases [
what's this?]
Get free weekly updates about FDA press releases, recalls, speeches, testimony and more.
FDA NewsroomFDA Home Page Search FDA Site FDA A-Z Index Contact FDA Privacy AccessibilityFDA Website Management StaffLabels: Death because of deliberate violations of production of prescription drugs.
April 23.2007. Massacre on the campus of Virginia Tech. 30 killed. The killer bought his guns two pistols on the Internet as well as the Ammo and and Clips.
Research shows us that in a densly populated society, stresses and tensions can bring people to the breaking point. Social Science research also shows that loss of jobs, failure etc make ordinary people into killers.
Add to this our Privacy laws, designed to protect coroportions from and hammer of justice and one has disaster in the making. If we did not have the privacy laws the mental health officials would have been free to contact the University of the potential danger.
And add to this the NRA and the other 2nd amendment nuts and death results.
Labels: The NRA and 2nd Amendment Absolutists kill in Virginia
